Main points
- MATADOR resources cannot stop buying this game producing cash flow.
- Tenaya Therapeutics has strong support from capitalists, institutions and analysts.
- Forssun Capital BancorP offers value after a failed merger; Opinion and institutions buy.
Inse by buying a purchase on NYSE (NYSE) First Capital Bancorp (NASDAQ: FSUN) In March. These companies are ranked high, if not in the first place, for a number of people who buy, and the number of purchased shares, and the amount that has been spent in dollars, respectively. The question is, what are the good buyers of investors, and is it time to buy it?
MATADOR resources cannot stop buying
Matador Resources is an independent oil and gas company in production operating in the United States. It is not strange for those familiar with those familiar with the balance for years. The activity of March 2025 is noticed because the arrow remains high in the list, as it ranks first for a number of people who buy. He bought nine of the informed, including CEO, Financial Director, Cao, CO, EVP, and directors, shares from late February to late March.
It should be noted that their activity is worth noting the size, which set a multi -year record, setting $ 1.1 million without any compensation sales. Opinion now has more than 6.1 % of shares and will continue to increase their property over time.
The profits are one of the reasons that make the people buy this arrow. The company is a strong profit motivation, as it produces about 2.45 % with stocks near $ 52.50 and a distribution farmer. Over the past few years, the company has increased the payment every few quarters, raised the payment by 1000 % in four years, and this trend is expected to continue.
The payment ratio is very low at 11 % and can maintain aggressive increases without business growth. Business growth is also good, as it works at a strong pace of two numbers in 2024, and is expected to maintain a pace of two numbers from low to low.
Opinion Penny Stock Tenaya Therapeutics
Tenaya Therapeutics occupies the highest number of stocks bought, which is not surprising, given the price of this Healthcare stock. Penny shares traded this less than $ 0.70 after years of landmark, providing a deep entry point. The problem for investors is that the buyer is a major shareholder, not a company executive – was sold for balance during the quarter. The main shareholder is the group of columns, which is the investment capital company that focuses on life sciences. I bought 35 million shares for approximately $ 25 million, up to more than 49 million or about 30 % of shares.
Tenaya focuses on a revolution in heart treatments. The research approach uses three companies targeting genetic therapy, cellular regeneration, and careful medicine. The company has many treatments in its pipeline, and positive experimental results are expected to be generated in 2025. Seven analysts assess unanimously as a purchase and see that it is advancing more than 1000 % at the low end of the target range. The institutions are also optimistic about this stock, as they have more than 90 % of them and are installed by the purchase activity to the highest level in the year 2025.
The Board of the Board of Directors of First Capital Bancorp Big
Forssun Capital Bancorp is a smaller regional bank working in the southwest. It is the most purchased by the familiar on the basis of the dollar, with one buyer, in this case a manager, is a single large purchase. The former director and executive of the FIRSTSUN MOLLIE H. Carter bought more than one million shares for a little more than $ 38 million, amounting to the total ownership of the shareholders and major shareholders to more than 37 %. Likewise, the institutions bought extensively in the first quarter and March 2025, and have another 37 % of the shares.
Among the incentives for purchase are deep value and cash flow expectations. After a failed merger, the shares are trading with a discount of its peer and its historical scope, which provides a large upside down head with analysts. Rising firstsun analysts, classifying a consensus of purchase with 20 % higher capabilities. The last coverage includes a newly initiated coverage by Mathew Clarak from the PIPER SANDLER and a repeated classification of Keefe, Bruyette and Woods. Both come with the goals of the consensus.
Companies in this article:
| a company | The current price | Change price | Profit | P/E ratio. | Consensus | The target consensus price |
|---|---|---|---|---|---|---|
| Tenaya Therapeutics (Tnya) | 0.65 dollars | -6.6 % | us | -0.45 | He buys | 6.25 dollars |
| Vsun Pancorp (FSUN) | $ 38.42 | level | us | us | He buys | 46.67 dollars |
| MTDR Resources | $ 52.43 | -1.0 % | 2.38 % | 7.34 | Moderate purchase | 74.50 dollars |
expertise
Thomas Hughes has been a shareholder on Insidertrades.com since 2019.
Experience areas
Technical Analysis, S & P 500; Retail, consumer, consumer foodstuffs, profits, high return, small hats, technology, economic data, oil, cryptocurrencies
education
Art partner in cooking technology
Experience of the past
Market Observer, trading and investor for many websites. Market Intelligence LLC was established to provide market research insights.
